Physicians and patients are benefiting from the SLT procedure in the following ways:

• Safety and efficacy

  SLT is safe and effective, and is not associated with systemic adverse effects.
  
  

• Patient compliance is not an issue

  SLT is performed by a physician and does not require patient compliance between physician visits
  
  

• Cost effective

  SLT provides economic benefits for the patient and the physician. Laser trabeculoplasty is a Medicare-covered procedure and is reimbursable under CPT code 65855.
  
  

• Latest technology

  New short-pulse, low fluence selective technology of the Selecta system provides pressure-lowering effects for your patients without compliance risks or systemic side effects.
  
  

• Selectivity

  Because of the specific wavelength of light generated, as well as the power and duration of the exposure, SLT selectively targets pigmented cells in the trabecular meshwork and causes no discernable damage to adjacent tissue. Researchers have found treated and untreated tissue to be nearly indistinguishable.*
  
  

• Treatment

  The intracellular microdisruption triggered by the laser is confined to the targeted cells. The laser activates specific biological mechanisms and minimizes thermal diffusion to surrounding non-pigmented cells, rather than coagulating or ablating tissue. The laser pulse is so short that heat caused within the targeted cells doesn't have time to spread to surrounding tissue.*
  
  

* Source: Ophthalmology Management, July 2000